Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-30

FDA Approved: ADALIMUMAB — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved the original application for the adalimumab biosimilar ADALIMUMAB-ADAZ from Sandoz Inc. The approval covers the same indications as the reference a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB-ADAZ (adalimumab)

Snippet

ORIG AP for ADALIMUMAB (ADALIMUMAB-ADAZ)